(PharmaNewsWire.Com, June 04, 2017 ) Accugenomics Inc (Accugenomics) is a provider of molecular diagnostics for cancer. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test and lung cancer diagnostic test. Accugenomics product candidates include LCDT-AGx-3 Gene lung cancer diagnostic tests that help improve diagnostic precision as an adjunct to morphological criteria and LCCT-AGx-4 Gene lung cancer chemoresistance test to estimate the response of different lung cancers to cisplatin or irinotecan related treatments. The company licensed its intellectual property from the University of Toledo. It operates through its development laboratory located in Wilmington. Accugenomics is headquartered in Wilmington, North Carolina, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Accugenomics Inc - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Accugenomics Inc Company Overview 4 Accugenomics Inc Company Snapshot 4 Accugenomics Inc Pipeline Products and Ongoing Clinical Trials Overview 4 Accugenomics Inc Pipeline Analysis Overview 7 Accugenomics Inc - Key Facts 7 Accugenomics Inc - Major Products and Services 8 Accugenomics Inc Pipeline Products by Development Stage 9 Accugenomics Inc Ongoing Clinical Trials by Trial Status 11 Accugenomics Inc Pipeline Products Overview 13 AccuKit 13 AccuKit Product Overview 13 Lung Cancer Chemoresistance Test - 4 Gene 14 Lung Cancer Chemoresistance Test - 4 Gene Product Overview 14 Lung Cancer Diagnostic Test - 3 Gene 15 Lung Cancer Diagnostic Test - 3 Gene Product Overview 15 Lung Cancer Risk Test - 15 Gene Test 16 Lung Cancer Risk Test - 15 Gene Test Product Overview 16 Lung Cancer Risk Test - 15 Gene Test Clinical Trial 17 .......
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
